Skip to main content
. 2009 Sep 14;587(Pt 21):5139–5147. doi: 10.1113/jphysiol.2009.174821

Figure 3. Involvement of different subtypes of mAChR in various phases of CCh-induced synaptic suppression of the hippocampal pathway.

Figure 3

A, time course of changes in EPSP slope of the hippocampal synapses under various conditions: CCh alone, CCh + M1 antagonist pirenzepine (2 μm), CCh + M2 antagonist AF-DX 116 (2 μm), and CCh + M1 + M2 antagonists. B, summarized EPSP reduction in both acute and sustained phases (*P < 0.05; **P < 0.01).